newsfilter
← Latest News
GlobeNewswire·

Rezolute Reports First Quarter Fiscal 2027 Financial Results and Provides Business Update

REDWOOD CITY, Calif., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Rezolute, Inc. (NASDAQ:RZLT) (Rezolute or the Company), a late-stage ultra-rare, metabolic disease company focused on treating refractory hypoglycemia caused by